# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-23-000039
Filing Date
2023-05-09
Accepted
2023-05-09 16:17:05
Documents
86
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | halo-20230331.htm iXBRL | 10-Q | 1687506
2 | EX-10.1 | ex101-amendmentno2tocredit.htm | EX-10.1 | 25038
3 | EX-31.1 | ex31110qq12023.htm | EX-31.1 | 13054
4 | EX-31.2 | ex31210qq12023.htm | EX-31.2 | 12994
5 | EX-32 | ex3210qq12023.htm | EX-32 | 13907
11 | GRAPHIC | halo-20230331_g1.jpg | GRAPHIC | 15840
12 | GRAPHIC | halo-20230331_g2.jpg | GRAPHIC | 112905
13 | GRAPHIC | halo-20230331_g3.jpg | GRAPHIC | 117013
| Complete submission text file | 0001159036-23-000039.txt |  | 8918367

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | halo-20230331.xsd | EX-101.SCH | 55491
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | halo-20230331_cal.xml | EX-101.CAL | 93020
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | halo-20230331_def.xml | EX-101.DEF | 300453
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | halo-20230331_lab.xml | EX-101.LAB | 684742
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | halo-20230331_pre.xml | EX-101.PRE | 469881
80 | EXTRACTED XBRL INSTANCE DOCUMENT | halo-20230331_htm.xml | XML | 1403867

Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 23902279
SIC: 2836 Biological Products, (No Diagnostic Substances)